Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Fate Therapeutics (FATE)
NASDAQ:FATE
Holding FATE?
Track your performance easily
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 3.07M | $ 6.77M | $ 1.93M | $ 1.68M | $ 1.94M |
| Gross Profit | $ 3.07M | $ 6.77M | $ 1.93M | $ 1.68M | $ 1.94M |
| EBIT | $ -47.68M | $ -38.43M | $ -46.61M | $ -48.08M | $ -51.28M |
| EBITDA | $ -43.07M | $ -31.07M | $ -44.42M | $ -43.19M | $ -46.54M |
| Net Income Common Stockholders | $ -47.68M | $ -38.43M | $ -48.00M | $ -44.12M | $ -45.17M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 296.92M | $ 304.88M | $ 383.54M | $ 315.18M | $ 349.73M |
| Total Assets | $ 494.97M | $ 528.82M | $ 569.89M | $ 506.22M | $ 543.79M |
| Total Debt | $ 98.98M | $ 100.56M | $ 102.07M | $ 103.54M | $ 104.95M |
| Net Debt | $ -197.94M | $ -204.32M | $ -281.47M | $ -211.64M | $ -244.78M |
| Total Liabilities | $ 132.64M | $ 131.84M | $ 143.78M | $ 137.80M | $ 141.01M |
| Stockholders Equity | $ 362.33M | $ 396.98M | $ 426.12M | $ 368.42M | $ 402.78M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -29.91M | $ -32.36M | $ -33.44M | $ -36.82M | $ -38.84M |
| Operating Cash Flow | $ -29.42M | $ -32.31M | $ -33.35M | $ -36.64M | $ -38.27M |
| Investing Cash Flow | $ 25.46M | $ -53.37M | $ 17.31M | $ 45.35M | $ 24.80M |
| Financing Cash Flow | - | $ 1.27M | $ 95.49M | $ -180.00K | - |